QA: GlobeStar Therapeutics Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2022_GlobeStar_Therapeutics_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001502152')"}

Graph

Absolute values for 0001502152, GlobeStar Therapeutics Corp

  xvar xval
0 AssetsCurrent 5,960
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 731,781
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 2,412
8 SellingGeneralAndAdministrativeExpense 9,091,817
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 707,399
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,960
1 Liabilities 731,781
2 Expenses 9,801,628
3 Revenues 0
4 StockholdersEquity -725,821
5 NetIncome -9,801,628
6 ComprehensiveNetIncome -9,801,628
7 BaseVar 5,269,684
8 EconomicCapitalRatio -30.0

Edgar->Model Mapping

Feature Distribution

Change over Time